Table 2.
Preoperative characteristics of patients according to surgical technique.
| RYGB | SG | Pa | |
|---|---|---|---|
| Count, n | 72 (41.9%) | 100 (58.1%) | |
| T2DM severity, n | |||
| Mild | 20 (27.8%) | 22 (22%) | 0.002 |
| Mod | 30 (41.7%) | 66 (66%) | |
| Severe | 22 (30.6%) | 12 (12%) | |
| Race, n | |||
| Malay | 56 (77.8%) | 81 (81%) | 0.189 |
| Chinese | 2 (2.8%) | 8 (8%) | |
| Indian | 11 (15.3%) | 10 (10%) | |
| Other ethnicities | 3 (4.2%) | 1 (1%) | |
| Age, years | 45.11 (SD 8.44) | 43.08 (SD 10.21) | 0.175 |
| Female, n | 60% (43) | 68% (68) | 0.332 |
| Duration of diabetes, years | 4.5 (IQR 9.0) | 2.0 (IQR 5.0) | 0.011 |
| BMI, kg/m2 | 40.7 (IQR 10.6) | 45.2 (IQR 12.7) | 0.006 |
| Number of medications, n | 1.69 (SD 1.16) | 1.0 (SD 0.83) | 0.031 |
| Insulin use, n | 28 (39%) | 20 (20%) | 0.009 |
| HbA1c, % | 8.05 (IQR 3.50) | 7.20 (IQR 2.30) | 0.194 |
| Glycemic control (HbA1c ≤ 6.5) | 19 (26%) | 29 (29%) | 0.734 |
RYGB: Roux-Y gastric bypass, SG: sleeve gastrectomy, BMI: Body mass index, aindependent t-test, Chi2, Mann–Whitney U test.